ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学術雑誌論文

The Potential of Bemegride as an Activation Agent in Electroencephalography in Dogs

https://az.repo.nii.ac.jp/records/2000292
https://az.repo.nii.ac.jp/records/2000292
41061dab-40a8-4398-b4ac-a157e3c76c55
名前 / ファイル ライセンス アクション
animals-12-03210.pdf animals-12-03210.pdf (2 MB)
Item type 学術雑誌論文 / Journal Article(1)
公開日 2025-02-14
タイトル
タイトル The Potential of Bemegride as an Activation Agent in Electroencephalography in Dogs
言語 en
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 Hirashima, Junya

× Hirashima, Junya

en Hirashima, Junya

Search repository
Saito, Miyoko

× Saito, Miyoko

en Saito, Miyoko

Search repository
Yokomori, Minoru

× Yokomori, Minoru

en Yokomori, Minoru

Search repository
Abstract
内容記述タイプ Abstract
内容記述 The present study investigated the potential of bemegride as a pharmacological activation agent that elicits epileptiform discharges (EDs) in interictal electroencephalogram (EEG) recordings in dogs. Four laboratory dogs with idiopathic epilepsy and four without epilepsy were included. The dogs were anesthetized using sevoflurane during EEG recordings. Bemegride was administered intravenously and repeatedly until EDs were enhanced or induced, or until the maximum dose (20 mg/kg) had been administered. Bemegride activated EDs in all dogs with epilepsy. These EDs predominantly occurred in each dog’s spontaneous irritative zones, which were identified without the administration of bemegride. EDs occurred after the administration of bemegride in 50% of dogs without epilepsy. The dose required for activation was significantly lower in dogs with epilepsy (median; 7.3 mg/kg) than in those without (median; 19.7 mg/kg) (p = 0.0294). The only suspected adverse effect associated with the administration of bemegride was vomiting in two dogs after awakening from anesthesia. There were no other adverse effects, including seizures. The present results demonstrated the potential of bemegride as a safe and effective pharmacological activation agent of EDs in anesthetized dogs with epilepsy and provided more options for the diagnosis and therapeutic planning of epilepsy, including presurgical evaluations, in dogs.
言語 en
書誌情報 Animals : an open access journal from MDPI

巻 12, 号 22, p. 1-13, 発行日 2022-11-19
出版者
出版者 MDPI
DOI
識別子タイプ DOI
関連識別子 10.3390/ani12223210
著者版フラグ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
査読
内容記述タイプ Other
内容記述 査読あり
戻る
0
views
See details
Views

Versions

Ver.1 2025-01-31 05:01:59.217313
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3